NinePointTwo Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

NinePointTwo Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,925	Closed	-$272K	–	342
2023 Q2	$272K	Buy	+6,925	New	+$244K	0.11%	82

NinePointTwo Capital's ISEE Position: Q3 2023 in Review

NinePointTwo Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 6,925 shares — an estimated $272K sold.

NinePointTwo Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $272K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

NinePointTwo Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
NinePointTwo Capital sold 6,925 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $272K.
NinePointTwo Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
NinePointTwo Capital's IVERIC bio, Inc. Common Stock position peaked at $272K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on NinePointTwo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.